Additional Content Download

Cell & Gene Therapy Manufacturing Agenda

Cell & Gene Therapy Manufacturing Agenda

Download the Cell and Gene Therapy Manufacturing Agenda to find out more about the speakers, sessions and content.

Cell & Gene Manufacturing: Emerging Trends

Cell & Gene Manufacturing: Emerging Trends

Pharma IQ spoke to Dr Ryan Guest, Director of Cell Production from cell therapy manufacturer Cellular Therapeutics to explore the raft of
emerging trends connected to cell and gene manufacturing.

Stem Cells: The Big Void of Toxicological Testing?

Stem Cells: The Big Void of Toxicological Testing?

In this interview Pharma IQ speak to James Sherley to find out what have been the major advancements in using stem cells for toxicology testing and the current challenges that need to be overcome in using stem cells for toxicology. In this interview you will also find out what are going to be the trends in using stem cells for toxicology over the coming 18 months.

INFOGRAPHIC: Global biomanufacturing activity & spend

INFOGRAPHIC: Global biomanufacturing activity & spend

Pharma IQ has created an easy-to-digest overview of biomanufacturing activity and spend around the world, whether they are already being implemented or have plans in the near future. You’ll be able to keep it as a handy reference, share it around your colleagues or even stick it on your wall!

Scale-Up and Manufacturing of Regenerative Medicine

Scale-Up and Manufacturing of Regenerative Medicine

When introducing a regenerative medicine cell based product to a commercial setting, there are a number of things to take into consideration to ensure a commercially viable and safe product for patient use. In this Q&A interview, William Fodor, Director of Translational Sciences, Cell Therapy Group, gives some great insights into the commercial manufacturing scale-up process of cell therapies.

Best Practice Guide Automation, Scale up & Scale Out

Best Practice Guide Automation, Scale up & Scale Out

One key point of focus for the market is not only the move towards scaling up - manufacturing bigger batches of product- but also scaling out - manufacturing more batches.

In response, to this Pharma IQ spoke to Elena Meurer of apceth GmbH & Co.KG to compile this best practise guide automation scale up –and scale out for cell and
gene therapies.